Showing results (211-220 of 317) with videos related to
Sort By:
Pageof 32
Investigative Ophthalmology & Visual Science|August 29, 2006
No pathogenic mutations identified in the COL8A1 and COL8A2 genes in familial Fuchs corneal dystrophyAnthony J Aldave, Sylvia A Rayner, Andrew K Salem, et al.Drug Delivery and Translational Research|May 8, 2020
An injectable microparticle formulation for the sustained release of the specific MEK inhibitor PD98059: in vitro evaluation and pharmacokineticsYoussef W Naguib, Brittany E Givens, Giang Ho, et al.Clinical Lymphoma & Myeloma|July 11, 2007
Duodenal mucosa-associated lymphoid tissue lymphoma successfully treated by radiation therapyCecilio Azar, Assaad Soweid, Zeina Berro, et al.Biomacromolecules|January 3, 2020
Poly(diaminosulfide) Microparticle-Based Vaccine for Delivery of Leptospiral AntigensEmad I Wafa, Jennifer H Wilson-Welder, Richard L Hornsby, et al.Archives of Ophthalmology (Chicago, Ill. : 1960)|March 12, 2008
A novel variant of combined granular-lattice corneal dystrophy associated with the Met619Lys mutation in the TGFBI geneAnthony J Aldave, Vivek S Yellore, Baris Sonmez, et al.Cancer Immunology Research|January 29, 2015
Three steps to breaking immune tolerance to lymphoma: a microparticle approachAmani Makkouk, Vijaya B Joshi, Caitlin D Lemke, et al.Trends in Molecular Medicine|May 5, 2026
Targeting the NAD+-PARP1-XRCC1 axis in ALSMd Ibrahim, Md Shahadat Hossain, Lezanne Ooi, et al.Vaccines|September 28, 2021
Monocytes Exposed to Immune Complexes Reduce pDC Type 1 Interferon Response to VidutolimodShakoora A Sabree, Caitlin D Lemke-Miltner, Sue E Blackwell, et al.Frontiers in Bioengineering and Biotechnology|August 5, 2022
Force-Bioreactor for Assessing Pharmacological Therapies for Mechanobiological TargetsAustin J Scholp, Jordan Jensen, Sathivel Chinnathambi, et al.Molecular Pharmaceutics|May 3, 2017
Cationic CaMKII Inhibiting Nanoparticles Prevent Allergic AsthmaAngie S Morris, Sara C Sebag, John D Paschke, et al.Pageof 32